Mibelle completes Mirexus asset deal

Mibelle completes Mirexus asset deal

THE WHAT? Mibelle Biochemistry has announced that it has successfully completed an asset deal with Mirexus. The transition is effective immediately and Mirexus’ branded products, PhytoSpherix, EnerZea, Adveen and Susttain, have all been fully integrated into Mibelle’s portfolio.

THE DETAILS As part of the deal, both parties have agreed not to disclose any further details.

“All of us at Mirexus are thrilled to find the ideal home for our technology at Mibelle Biochemistry. The deep knowledge and capabilities of Mibelle will enable the growth of this technology beyond what Mirexus could do on its own. We look forward to seeing the continued expansion of our technology under Mibelle’s experienced leadership,” said Phil Whiting, President & CEO of Mirexus Biotechnologies Inc.

THE WHY? The completion of this asset deal strengthens Mibelle Biochemistry’s active ingredient portfolio and enhances its position as a developer and manufacturer of active ingredients for the cosmetics and nutraceuticals industries.